{
 "id": "MedOtter/ISPY1-Tumor-SEG-Radiomics",
 "owner": "MedOtter",
 "name": "ISPY1-Tumor-SEG-Radiomics",
 "downloads": 1109,
 "likes": 0,
 "last_modified": "2026-08-07T20:50:15.000Z",
 "stated_licence": "cc-by-3.0",
 "stated_from": "tag",
 "licence_name": null,
 "licence_link": null,
 "file_licence": null,
 "licence_files": [],
 "sources": [],
 "gated": false,
 "tasks": [
  "image-segmentation"
 ],
 "citation": "> Chitalia R, Pati S, Bhalerao M, Thakur SP, Jahani N, Belenky V, McDonald ES, Gibbs J,\n> Newitt DC, Hylton NM, Kontos D, Bakas S. Expert tumor annotations and radiomics for\n> locally advanced breast cancer in DCE-MRI for ACRIN 6657/I-SPY1. *Scientific Data* 9, 440\n> (2022). doi:10.1038/s41597-022-01555-4\n\n> Chitalia R, et al. (2021). Expert tumor annotations and radiomic features for the\n> ISPY1/ACRIN 6657 trial data collection [Data set]. The Cancer Imaging Archive.\n> doi:10.7937/TCIA.XC7A-QT20\n\n> Newitt D, Hylton N, on behalf of the I-SPY 1 Network and ACRIN 6657 Trial Team (2016).\n> Multi-center breast DCE-MRI data and segmentations from patients in the I-SPY 1/ACRIN\n> 6657 trials [Data set]. The Cancer Imaging Archive. doi:10.7937/K9/TCIA.2016.HdHpgJLK\n\n> Hylton NM, et al. Locally advanced breast cancer: MR imaging for prediction of response\n> to neoadjuvant chemotherapy - results from ACRIN 6657/I-SPY TRIAL. *Radiology*\n> 263(3):663-672 (2012). doi:10.1148/radiol.12110748",
 "signal": "permissive",
 "reason": "The declared licence (cc-by-3.0) is classified as permissive.",
 "revision": "dd4bbffd69294daab3bfdc1999625313578f4c2c",
 "stated_evidence": "https://huggingface.co/datasets/MedOtter/ISPY1-Tumor-SEG-Radiomics/blob/dd4bbffd69294daab3bfdc1999625313578f4c2c/README.md",
 "file_evidence": "https://huggingface.co/datasets/MedOtter/ISPY1-Tumor-SEG-Radiomics/tree/dd4bbffd69294daab3bfdc1999625313578f4c2c",
 "card_nc": false
}